Mutation Patterns at Codons Rt204 And Rt180 of the HBV PolymeraseGene Associated with Lamivudine Resistance in Treated and UntreatedChronic HBV Patients in Kuwait: A Case Series
暂无分享,去创建一个
[1] Suhail Ahmad,et al. Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates , 2010, Virology Journal.
[2] H. Keyvani,et al. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[3] Yoshiyuki Suzuki,et al. Clinical and virological features of non‐breakthrough and severe exacerbation due to lamivudine‐resistant hepatitis B virus mutants , 2006, Journal of medical virology.
[4] H. Janssen,et al. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression? , 2006, The Netherlands journal of medicine.
[5] N. Enomoto,et al. Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B , 2005, Intervirology.
[6] Mei Huang,et al. YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines. , 2005, World journal of gastroenterology.
[7] R. Goldin,et al. Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. , 2005, Journal of hepatology.
[8] E. Mokaddas,et al. Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. , 2004, Molecular and cellular probes.
[9] G. Kim,et al. Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection , 2004, Journal of Korean medical science.
[10] K. Chayama,et al. Rare Quasispecies in the YMDD Motif of Hepatitis B Virus Detected by Polymerase Chain Reaction with Peptide Nucleic Acid Clamping , 2003, Intervirology.
[11] Michael D. Miller,et al. The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro , 2003, Journal of Virology.
[12] S. Fan,et al. Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations. , 2003, Journal of hepatology.
[13] Ching-Lung Lai,et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Yoshiyuki Suzuki,et al. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine , 2003, Journal of Gastroenterology.
[15] T. Okanoue,et al. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. , 2002, Journal of hepatology.
[16] M. Sata,et al. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. , 2001, Journal of hepatology.
[17] D. Richman,et al. Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.
[18] J. Villeneuve,et al. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. , 2000, Journal of hepatology.
[19] E. Schiff,et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.
[20] C. Chu,et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.
[21] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .
[22] D. Pillay,et al. Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance , 1998 .
[23] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. , 1998, Hepatology.